This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The FDA’s current draft guidance on the approval process for AI devices does not specify the type of validation the agency recommends manufacturers use.
Annual screening mammography is tied to lower risk of late-stage cancer and better overall survival among women, researchers have reported. A team led by Margarita Zuley, MD, from the University of Pittsburgh found that across various clinical and demographic subgroups, women who undergo annual screening have 5% and 10% fewer late-stage cancers than women who undergo biennial and intermittent screening.
We use the word 'love' in a bewildering range of contexts -- from sexual adoration to parental love or the love of nature. Now, more comprehensive imaging of the brain may shed light on why we use the same word for such a diverse collection of human experiences.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Early brain accumulation of amyloid plaque on PET scans is associated with emerging depressive symptoms in cognitively unimpaired older adults, according to a study published August 29 in JAMA Network Open. The finding has implications for recognizing individuals in preclinical Alzheimer's disease stages who may be candidates for depression treatment, noted lead author Catherine Munro, PhD, a neurologist at Brigham and Women's Hospital in Boston.
The month of August has been almost exclusively related to the usual activities of daily living and the new/growing job board I’ve started dedicated to true independent physician-owned radiology private practices, which now has 45 groups. I know a service like Independent Radiology probably has more impact than my usual sporadic writing, but I’m personally looking forward to getting back to my usual idiosyncrasies in September.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Practices that reported under the Merit-based Incentive Payment System (MIPS) of the Quality Payment Program (QPP) for 2023 can now get their performance score and find out how it will impact their Medicare reimbursement in 2025. The first step is to sign in to the QPP website to get your own practice’s results and review it for any discrepancies. The U.S.
Preventive health screenings are a cornerstone of modern healthcare, enabling the early detection and management of potential health issues before they develop into more serious conditions. Among the most vital tools in this preventive health is diagnostic imaging. From X-rays and ultrasounds to MRIs and CT scans, these technologies provide invaluable insights into the body’s internal structures, allowing for precise diagnosis and effective treatment planning.
There has been a "notable" uptick in interest for diagnostic and interventional radiology, with experts recommending a shift in strategy to help standout in the process.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Radiologists can help reduce unnecessary follow-up work in patients with suspected oropharynx cancer by analyzing certain metrics on PET/CT scans, according to a team of head and neck surgeons at the Mayo Clinic in Rochester, MN. In an analysis of cases where F-18 FDG radiotracer uptake was reported as suspicious for oropharynx cancer on PET/CT scans, the number of patients who were actually diagnosed was low, the group found.
Researchers have developed an artificial intelligence which can differentiate cancer cells from normal cells, as well as detect the very early stages of viral infection inside cells. The findings pave the way for improved diagnostic techniques and new monitoring strategies for disease. The AI can detect rearrangements inside cells as small as 20nm, or 5,000 times smaller than the width of a human hair.
"This reduced talent pool, coupled with increasing demands in radiology, will negatively affect the quality and access to care for patients," experts wrote in JACR.
This is a photo gallery of artificial intelligence products cleared for clinical use in medical imaging by the U.S. Food and Drug Administration. Radiology by far is the leader of all clinical AI FDA approvals.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Using digital breast tomosynthesis (DBT) and supplemental MRI yields more benefits but also confers more risks, according to simulation data published August 26 in JAMA Internal Medicine. Researchers led by Natasha Stout, PhD, from Harvard Medical School in Boston, MA, found that while DBT plus supplemental breast MRI leads to more deaths averted, it also leads to more false-positive recalls and false-positive biopsy recommendations for women of most breast density categories.
The less control a person has over their diabetes, the greater the difference between chronological age and estimated brain age based on MRI markers, according to the study.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
“Living” and “viable” should be avoided in first-trimester ultrasound lexicon when imaging pregnant women, according to new guidelines introduced August 27 by the Society of Radiologists in Ultrasound (SRU), published in Radiology. In what the RSNA is calling a first, the lexicon developed by a multisociety panel addresses terms frequently used in first-trimester ultrasound reports, such as “ectopic pregnancy,” “heartbeat,” “living,” and “viable.
Commitment to work-life balance, physician autonomy, positive atmosphere and management that treats staff well were listed as key elements of a healthy workplace.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content